| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-15 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-05 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |